- 专利标题： Rapaglutins, novel inhibitors of GLUT and use thereof
-
申请号： US16074300申请日： 2017-02-03
-
公开(公告)号： US11708391B2公开(公告)日： 2023-07-25
- 发明人: Jun Liu , Jingxin Wang , Zufeng Guo
- 申请人： The Johns Hopkins University
- 申请人地址： US MD Baltimore
- 专利权人： The Johns Hopkins University
- 当前专利权人： The Johns Hopkins University
- 当前专利权人地址： US MD Baltimore
- 代理机构： DLA Piper LLP (US)
- 国际申请： PCT/US2017/016516 2017.02.03
- 国际公布： WO2017/136731A 2017.08.10
- 进入国家日期： 2018-07-31
- 主分类号： C07K5/10
- IPC分类号： C07K5/10 ; C07K5/103 ; A61P35/00 ; A61K9/00 ; A61K31/12 ; A61K31/167 ; A61K31/235 ; A61K31/353 ; A61K31/407 ; A61K31/4406 ; A61K38/12 ; A61K45/06 ; C07K5/117 ; C07K5/12
摘要：
Compounds with the following structures
and their analogs are provided. Compositions that include these structures can be used to inhibit glucose transporters and stop or decrease the proliferation of cancer, treat possible organ rejection and treat autoimmune disease.
and their analogs are provided. Compositions that include these structures can be used to inhibit glucose transporters and stop or decrease the proliferation of cancer, treat possible organ rejection and treat autoimmune disease.
公开/授权文献
- US20210214390A1 RAPAGLUTINS, NOVEL INHIBITORS OF GLUT AND USE THEREOF 公开/授权日：2021-07-15
信息查询
